Home » Topics » Regulatory

Regulatory
RSS

NexMed completes phase I trial of ED product

Feb. 4, 1998

Crescendo and Alza to collaborate on chronic pain product

Feb. 3, 1998

Topical interferon alfa enters phase II for intravaginal warts

Feb. 2, 1998

Controlled-release oxybutynin to be marketed in Europe by Synthelabo

Feb. 2, 1998

Suramin submitted for FDA approval for cancer indication

Jan. 30, 1998

Proleukin cleared for marketing in U.S. for melanoma indication

Jan. 30, 1998

Anesta signs European marketing agreement for Actiq

Jan. 29, 1998

New once-daily rosacea therapy introduced in U.S.

Jan. 27, 1998

Once-daily hair loss treatment available throughout the U.S.

Jan. 27, 1998

Botox compared to saline for chronic anal fissure

Jan. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Deals and an M&A strengthen end-of-year numbers
BioWorld
Two large deals and an acquisition, totaling about $4.64 billion in all, are helping wrap up what’s turning out to be a strong year. Through the first 11 months...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Radiopharm Theranostics’ RAD-101 meets brain metastases endpoints
BioWorld
Radiopharm Theranostics Ltd.’s radiotracer RAD-101 met the primary endpoint in 92% of patients in the phase IIb imaging trial in brain metastases, according to...